Seshu Tyagarajan - 25 Jun 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Technology Officer
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Seshu Tyagarajan
Issuer symbol
CADL
Transactions as of
25 Jun 2025
Net transactions value
+$24,999
Form type
4
Filing time
26 Jun 2025, 08:30:14 UTC
Previous filing
20 Mar 2025
Next filing
28 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tyagarajan Seshu Chief Technology Officer C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM /s/ Charles Schoch, as Attorney-In-Fact for Seshu Tyagarajan 26 Jun 2025 0001923794

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Award $24,999 +5,353 +6.3% $4.67 90,865 25 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.